explore -WSS

explore

author：comprehensive 2025-09-29 02:33:48 - browse：1

Truvian Health employee with a plate holding reagents used to measure commonly tested blood markers. Truvian

SAN DIEGO — Truvian Health, a San Diego blood diagnostics company, shared data on Tuesday showing that its benchtop instrument’s results are largely consistent with those generated by large central laboratories. But while the results lend support for the company’s vision of decentralized and widely available clinical testing, they also resurface questions about the value of an approach widely associated with the now defunct and notorious Bay Area startup Theranos.

In a multisite study, the company tested nearly 240 blood samples from healthy donors and chronic disease patients for dozens of blood-based measurements commonly ordered by doctors, from cholesterol to blood sugar to blood cell counts. Results from Truvian’s benchtop analytical instrument, with few exceptions, closely matched readings from devices used in large central labs and made by Swiss pharma giant Roche and Japanese firm Sysmex.

The findings were presented at the annual meeting of the American Association for Clinical Chemistry, recently rebranded as the Association for Diagnostics & Laboratory Medicine. It’s the first time Truvian has shared clinical data on its product, though they have not been published in a peer-reviewed journal. The company, which is planning additional validation studies, expects to submit for Food and Drug Administration approval of its device by the third quarter of 2024.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

Wikipedia

WSS

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

How generative AI is inspiring dreams of a health data revolution

Advances in CAR

Stem cell treatment guidelines are released by FDA

A rare thyroid diagnosis led to unexpected, all

JPM 2024: Verve Therapeutics looks to mainstream genome editing

entertainment

explore

focus

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Generative AI mines health records to identify patients’ social needs

Sports medicine is finally prioritizing gender equality

Trump surgeon general acknowledges mistakes during Covid

Malaria cases in Florida and Texas: Here’s what you need to know

Covid hospitalizations on the rise, Humana says

Tori Bowie and the unacceptable rates of Black maternal death

Risky weight loss products often used by teens globally, per study

Malaria cases in Florida and Texas: Here’s what you need to know

Risky weight loss products often used by teens globally, per study

focus

Crinetics acromegaly drug succeeds in late

Generative AI mines health records to identify patients’ social needs

Why liver experts renamed NASH to MASH, and NAFLD to MASLD

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

Amazon on where the company's health care bets are headed next

Crinetics acromegaly drug succeeds in late

entertainment

Wikipedia

focus

Wikipedia